SERPING1 Protein (Transcript Variant 1)
Quick Overview for SERPING1 Protein (Transcript Variant 1) (ABIN2731841)
Target
See all SERPING1 ProteinsProtein Type
Biological Activity
Origin
Source
Application
Purity
-
-
Protein Characteristics
- Transcript Variant 1
-
Specificity
- Optimal preservation of protein structure, post-translational modifications and functions.
-
Characteristics
-
- Recombinant human SERPING1 / C1 Inhibitor (transcript variant 1) protein expressed in CHO cells.
- Produced with end-sequenced ORF clone
- Tested for bioactivity.
-
Endotoxin Level
- Endotoxin level is <0.1 ng/μg of protein (<1EU/μg).
-
Biological Activity Comment
- Measured by its ability to inhibit recombinant human complement component C1a cleavage of a colorimetric peptide substrate, N Carbobenzyloxy-Lys-ThioBenzyl ester (Z-K-SBzl). The expected IC50 is less than or equal to 2.6 nM.
-
-
Want other Options for this Protein ?
!Discover Our Predefined Custom Proteins and Custom Protein Services!Your project requires further customization? Contact us and discover our custom protein solutions
-
-
-
Application Notes
-
Recombinant human proteins can be used for:
Native antigens for optimized antibody production
Positive controls in ELISA and other antibody assays
Protein-protein interaction
In vitro biochemical assays and cell-based functional assays -
Restrictions
- For Research Use only
-
-
-
Buffer
- Lyophilized from a 0.2 μM filtered solution of 20 mM phosphate buffer,100 mM NaCl, pH 7.2
-
Handling Advice
- Resuspend the protein in the desired concentration in proper buffer
-
Storage
- -80 °C
-
Storage Comment
- Store at -80°C. Thaw on ice, aliquot to individual single-use tubes, and then re-freeze immediately. Only 2-3 freeze thaw cycles are recommended.
-
-
- SERPING1 (Serpin Peptidase Inhibitor, Clade G (C1 Inhibitor), Member 1 (SERPING1))
-
Alternative Name
- Serping1,c1 Inhibitor
-
Background
- This gene encodes a highly glycosylated plasma protein involved in the regulation of the complement cascade. Its protein inhibits activated C1r and C1s of the first complement component and thus regulates complement activation. Deficiency of this protein is associated with hereditary angioneurotic oedema (HANE). Alternative splicing results in multiple transcript variants encoding the same isoform.
-
Molecular Weight
- 49.4 kDa
-
NCBI Accession
- NP_000053
-
Pathways
- Complement System
Target
-